A solvent-free protocol for the green synthesis of arylalkylidene rhodanines in a task-specific ionic liquid

2-Hydroxyethylammonium formate acts as a task-specific ionic liquid (TSIL) for the Knoevenagel condensation of carbonyl compounds with rhodanine to afford arylalkylidene rhodanines under solvent-fr...

[1]  Wing‐Leung Wong,et al.  Recent development in functionalized ionic liquids as reaction media and promoters , 2012 .

[2]  H. Shaterian,et al.  Domino Knoevenagel condensation, Michael addition, and cyclization using ionic liquid, 2-hydroxyethylammonium formate, as a recoverable catalyst , 2011 .

[3]  D. Fang,et al.  Green synthesis of 5-benzylidene rhodanine derivatives catalyzed by 1-butyl-3-methyl imidazolium hydroxide in water , 2008 .

[4]  M. Degani,et al.  Green and mild protocol for hetero-Michael addition of sulfur and nitrogen nucleophiles in ionic liquid , 2007 .

[5]  M. Rahmouni,et al.  A practical access to novel 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones via sulfur/nitrogen displacement under solvent-free microwave irradiation , 2007 .

[6]  R. Enriz,et al.  Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. , 2007, Bioorganic & medicinal chemistry.

[7]  M. Prezhdo,et al.  Rhodanine derivatives as inhibitors of JSP-1. , 2005, Bioorganic & medicinal chemistry letters.

[8]  N. Bıçak A new ionic liquid: 2-hydroxy ethylammonium formate , 2005 .

[9]  A. D. Buss,et al.  Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase. , 2002, Bioorganic & medicinal chemistry letters.

[10]  M. Sim,et al.  Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. , 2001, Bioorganic & medicinal chemistry letters.

[11]  M. Sim,et al.  Solid-phase combinatorial synthesis of 5-arylalkylidene rhodanine , 2000 .

[12]  K. Shimotohno,et al.  Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. , 1997, Biochemical and biophysical research communications.

[13]  B. Lohray,et al.  Novel indole containing thiazolidinedione derivatives as potent euglycemic and hypolipidaemic agents , 1997 .

[14]  T. Sohda,et al.  Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds. , 1991, Chemical & pharmaceutical bulletin.

[15]  T. Takano,et al.  Preparations of 5-alkylmethylidene-3-carboxymethylrhodanine derivatives and their aldose reductase inhibitory activity. , 1990, Chemical & pharmaceutical bulletin.

[16]  S. Singh,et al.  Chemistry and biological activity of thiazolidinones , 1981 .

[17]  C. Bradsher,et al.  RHODANINE DERIVATIVES OF KETONES1 , 1950 .